Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences Licenses OncoMethylome Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences has licensed exclusive, worldwide rights from OncoMethylome Sciences to DNA methylation biomarkers for use in the stool-based detection of colorectal cancer.

In addition, Madison, Wis.-based Exact Sciences also licensed non-exclusive access to part of OncoMethylome's platform technology. In return, the Belgian firm will receive milestone payments and royalties on net sales

Exact Sciences' primary product, which is currently in development, is a stool-based DNA test for colorectal cancer screening. The agreement with OncoMethylome follows last year's licensing of worldwide rights to Hologic's Invader plus and real-time Invader detection chemistries for colorectal screening applications.

"Our team has developed a new approach to stool-DNA testing that uniquely includes multiple methylation markers in a single assay, and achieves exceptionally high sensitivity and specificity," Exact Sciences President and CEO Kevin Conroy said in a statement. "The inclusion of these markers makes us even more confident about the likelihood of success with our upcoming validation study."

He added that the firm intends to discuss the results of that study on Oct. 29, at the American Association of Cancer Research meeting in Philadelphia.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.